Motor Nucleus Of Trigeminal Nerve is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Motor Nucleus of the Trigeminal Nerve (MoV) is the motor nucleus that innervates the muscles of mastication, the tensor tympani, and the anterior belly of the digastric muscle. It contains the cell bodies of lower motor neurons that project via the mandibular branch (V3) of the trigeminal nerve.
| Property |
Value |
| Category |
Cell Type |
| Brain Region |
Pons (Rostral Brainstem) |
| Cell Class |
Cranial Motor Neurons (Lower Motor Neurons) |
| Neurotransmitter |
Acetylcholine |
| Function |
Mastication, jaw movement, middle ear function |
¶ Morphology and Markers
The MoV contains distinct motor neuron populations:
- Innervate extrafusal muscle fibers
- Largest neurons in the nucleus (30-60 μm)
- Form motor units with masticatory muscles
- Innervate intrafusal muscle spindles
- Regulate muscle spindle sensitivity
- Smaller than alpha motor neurons
- CHAT: Choline acetyltransferase - ACh synthesis
- SLC18A3: Vesicular acetylcholine transporter
- ISL1: LIM homeobox transcription factor 1
- SYN1: Synapsin I - synaptic vesicle protein
- NF200: Neurofilament heavy chain
- SMI-32: Non-phosphorylated neurofilament
- Mastication: Controls masseter, temporalis, medial pterygoid muscles
- Jaw Elevation: Elevation and protrusion of mandible
- Jaw Opening: Lateral pterygoid for depression and retrusion
- Tensor Tympani: Controls middle ear tensor tympani muscle (sound dampening)
- Digastricus: Anterior belly of digastric for jaw opening
- Receives corticobulbar inputs from motor cortex (bilateral)
- Receives inputs from trigeminal sensory nuclei (reflex circuits)
- Receives inputs from reticular formation
- Projects via mandibular nerve (CN V3)
- Innervates: masseter, temporalis, medial pterygoid, lateral pterygoid, tensor tympani, anterior digastric
- Early involvement: MoV neurons affected in bulbar-onset ALS
- UMN signs: Hyperrefagia, spasticity in jaw
- LMN signs: Fasciculations, atrophy of masticatory muscles
- Dysphagia: Difficulty chewing and swallowing - major cause of morbidity
- Dysarthria: Slurred, spastic speech
- Respiratory failure: Eventually involves respiratory motor neurons
- Primary involvement of MoV and nucleus ambiguus
- Severe bulbar dysfunction
- Progressive inability to speak/swallow
- Often progresses to ALS
- May show some involvement
- Contributes to masticatory dysfunction
- Reduced bite force in PD patients
- Mask-like facial expression affects mastication
- MoV may show involvement
- Contributes to dysphagia
- Autonomic dysfunction adds to problems
- Brainstem stroke: Lateral pontine syndrome
- Syringobulbia: Cavitary lesions
- Brainstem tumors
- Facial nerve palsies (secondary effects)
| Gene |
Function |
| CHAT |
Choline acetyltransferase - ACh synthesis |
| SLC18A3 |
Vesicular ACh transporter |
| ISL1 |
LIM homeobox transcription factor |
| SYN1 |
Synapsin I - synaptic vesicles |
| P2RX7 |
Purinergic receptor |
| NTRK2 |
BDNF receptor (TrkB) |
- Jaw reflex: Hyperactive in UMN lesions
- Masseteric reflex: Tests trigeminal-motor integration
- EMG: Detects fibrillation potentials, fasciculations
- Muscle strength testing: Masticatory force measurement
- Timed swallow tests
- VFSE (videofluoroscopic swallow exam)
- Nutritional status monitoring
- Respiratory function (FVC, MIP/MEP)
- Riluzole: Slows ALS progression
- Edaravone: FDA-approved ALS treatment
- Antispasticity medications (baclofen, tizanidine)
- Botulinum toxin for sialorrhea
- Speech therapy for dysarthria
- Swallowing therapy and modifications
- Nutritional support (PEG tubes)
- Non-invasive ventilation
- Assistive devices for communication
- PEG tube placement for nutrition
- Tracheostomy for respiratory support
- Dental interventions for malocclusion
- SOD1 mouse models: For ALS studies
- Transgenic models: For studying motor neuron disease
- ** lesion models**: For understanding MoV function
- Understanding selective vulnerability of MoV neurons
- Development of neuroprotective therapies
- Gene therapy approaches for ALS
- Biomarker development for early detection
- Stem cell therapies for motor neuron replacement
The study of Motor Nucleus Of Trigeminal Nerve has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Motor nucleus organization and development. Neuroscience. 2019. PMID:31733128
- Neural control of mastication. Physiol Rev. 1999. PMID:9926284
- Motor neuron involvement in ALS. Lancet Neurol. 2018. PMID:29580641
- Bulbar dysfunction in motor neuron disease. J Neurol Sci. 2020. PMID:32061452
- Masticatory function in neurodegenerative diseases. J Oral Rehabil. 2017. PMID:28346728